Patient controlled analgesia 5 mark answer for anesthesia exam
Reading File
Finding Sources
Finding Sources
Searching PubMed
"patient-controlled analgesia" postoperative pain
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive, authoritative content from Miller's Anesthesia and Barash's Clinical Anesthesia. Here is the complete 5-mark exam answer:
Patient Controlled Analgesia (PCA)
Definition
PCA is any technique of pain management that allows patients to self-administer analgesia on demand. The patient activates a programmed pump by pressing a button, delivering a preset bolus of analgesic. It is most commonly used for postoperative pain management via the intravenous route (IV-PCA).
- Barash, Cullen & Stoelting's Clinical Anesthesia, 9e
- Miller's Anesthesia, 10e
Rationale / Principle
Traditional PRN (as-needed) regimens fail due to:
- Wide interpatient variability in analgesic needs
- Variable serum drug levels (especially with IM injection)
- Administrative delays in nurse-administered analgesia
IV-PCA is based on a negative-feedback loop: when pain is experienced, the patient self-administers analgesic; when pain subsides, demands stop. If the loop is violated (e.g., background infusion in opioid-naive patients), respiratory depression may occur.
Programmable Variables (5 Key Variables)
| Variable | Description | Typical Value (Morphine) |
|---|---|---|
| Bolus (demand) dose | Amount delivered per press | 0.5-2 mg |
| Lockout interval | Minimum time between doses | 5-10 minutes |
| Background infusion | Continuous basal rate | Not recommended in opioid-naive |
| 1-hour limit | Max dose in 1 hour | - |
| 4-hour limit | Max dose in 4 hours | 30 mg |
Commonly Used Drugs and Doses
| Drug | Concentration | Demand Dose | Lockout | Max in 4 h |
|---|---|---|---|---|
| Morphine | 1 mg/mL | 0.5-2 mg | 5-10 min | 30 mg |
| Hydromorphone | 0.2 mg/mL | 0.1-0.4 mg | 10 min | 6 mg |
| Fentanyl | 10 mcg/mL | 5-20 mcg | 4-10 min | 300 mcg |
- Hydromorphone is preferred in renal failure over morphine.
- Fentanyl has no active metabolites, making it ideal in renal/hepatic impairment.
- Meperidine is contraindicated due to accumulation of the toxic metabolite normeperidine.
Routes of PCA
- IV-PCA - most common; systemic opioid delivery
- Epidural PCA (EPCA) - opioid +/- local anesthetic; superior analgesia at rest vs. IV-PCA, though the additional pain reduction is modest
- Subcutaneous PCA - used when IV access is difficult
- Intranasal / transmucosal PCA - less common
- Remifentanil PCA - used in labor analgesia when epidural is contraindicated (requires strict monitoring due to risk of maternal oxygen desaturation)
Advantages over PRN (Nurse-Administered) Analgesia
- Superior postoperative analgesia with lower pain scores
- Higher patient satisfaction - patients value perceived control and independence
- Avoids delays in obtaining medication from nursing staff
- Accounts for pharmacokinetic/pharmacodynamic variability between individuals
- Incidence of respiratory depression (~1.5%) is no greater than with PRN systemic opioids
Background Infusion: Key Points
- Opioid-naive adults: Background infusion is NOT recommended - it increases opioid consumption and the risk of respiratory depression without improving analgesia or sleep quality
- Opioid-tolerant patients: A background infusion may be appropriate
- Pediatric patients: Background infusion can be effective
Contraindications / Risk Factors
Relative contraindications to standard PCA dosing (if >2 factors present, use with extreme caution):
- Obstructive sleep apnea
- Pulmonary disease
- Renal or hepatic dysfunction
- Congestive heart failure
- Closed head injury
- Altered mental status
- Elderly patients (reduce dose)
Side Effects
| Side Effect | Management |
|---|---|
| Nausea/vomiting | Ondansetron, dopamine antagonists, dexamethasone, dexmedetomidine |
| Pruritus | Diphenhydramine, low-dose naloxone, nalbuphine |
| Respiratory depression | Reduce/stop PCA, naloxone, monitoring |
| Excessive sedation | Change opioid, reduce dose |
| Confusion | Reassess appropriateness of PCA |
Errors and Problems with PCA
Operator errors:
- Misprogramming the device
- Failure to clamp/unclamp tubing
- Improperly loading syringe or cartridge
Patient errors:
- Failure to understand PCA therapy
- Proxy activation (e.g., family pressing the button - a serious safety concern)
- Intentional analgesic abuse
Mechanical errors:
- Failure to deliver on demand
- Defective one-way valve at Y-connector
- Faulty alarm system
Monitoring Requirements
- Continuous pulse oximetry and end-tidal CO2 monitoring in the early postoperative period
- Especially important in: elderly, obese, OSA, low body weight, opioid-naive patients, concurrent sedatives
- Initial pain control should be established in PACU/ICU before PCA initiation
Role in Multimodal Analgesia
PCA is ideally combined with non-opioid adjuncts (opioid-sparing strategy):
- NSAIDs / COX-2 inhibitors
- Acetaminophen (paracetamol)
- NMDA antagonists (ketamine)
- Alpha-2 agonists (dexmedetomidine)
- Regional anesthesia (epidural, peripheral nerve blocks)
This reduces total opioid dose and minimizes opioid-related adverse effects.
Summary for exam: PCA exploits a negative-feedback principle to individualize pain control, using programmable bolus dose, lockout interval, and optional background infusion. The most important safety feature is the lockout interval. Background infusion is avoided in opioid-naive adults. Morphine is the standard drug; fentanyl is preferred in organ impairment; meperidine is contraindicated. PCA achieves superior analgesia and patient satisfaction compared to PRN regimens, with no higher rate of serious adverse events when used correctly.
This is a shared conversation. Sign in to Orris to start your own chat.